NCT07709702

Brief Summary

This study aims to compare two feeding approaches after surgery for biliary atresia and choledochal cyst in children. Traditionally, children are kept without oral feeding for more than 48 hours after these operations until bowel activity returns. However, newer Enhanced Recovery After Surgery (ERAS) programs suggest that starting feeding earlier may help children recover faster. In this study, children undergoing surgery for biliary atresia or choledochal cyst will be randomly assigned to one of two groups. One group will start oral liquids within 24 hours after surgery and gradually progress to normal feeding as tolerated (early feeding group). The other group will receive conventional care, where feeding is started after more than 48 hours once bowel activity has returned. Researchers will compare both groups for postoperative complications such as wound infection and anastomotic leakage, as well as the duration of hospital stay. Additional observations will include vomiting, abdominal distension, need for reinsertion of a nasogastric tube, requirement for repeat surgery, and time taken to resume normal feeding. Participation in the study will not affect the standard surgical treatment provided. All children will receive routine perioperative care and will be monitored closely throughout their hospital stay and follow-up visits. The findings of this study may help determine whether early oral feeding is a safe and effective strategy to improve recovery and reduce hospitalization after pediatric hepatobiliary surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 13, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

1.9 years

First QC Date

June 13, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

ERASCholedochal CystPediatricChildrenPost-Operative ManagementBiliary AtresiaFeeding ProtocolFast-Tract DischargeHospital Stay

Outcome Measures

Primary Outcomes (3)

  • Wound Infection

    Condition characterized with presence of redness, swelling, warmth, pain or purulent discharge from surgical site classified according to CDC SSI grading.

    Within 04 weeks of surgery

  • Anastomotic Leak

    When surgical anastomosis fails and there is leakage proven with signs of peritonitis on clinical examination, pneumoperitoneum on radiographs

    Within hospital stay or on readmission within 1 month

  • Length of Hospital Stay

    Duration of stay measured in days

    From the date of surgery until the date of hospital discharge, assessed up to 30 days

Secondary Outcomes (3)

  • Vomiting

    From start of feeding till 30 days post-operatively

  • Abdominal Distension

    from initiation of oral feeds till 30 days post-operatively

  • Need for Re-operation

    From start of oral feeds till 04 weeks post-op

Study Arms (4)

ERAS Feeding Protocol in Choledochal Cyst

EXPERIMENTAL

The patients with Roux-en-Y hepaticojejunostomy for choledochal cyst will be started oral liquids within 24 hours of surgery, NG Tube will be removed before starting oral feeds

Other: Enhanced Recovery After Surgery

Conventional Feeding Protocol in Choledochal Cyst

ACTIVE COMPARATOR

The post operative patients of Roux-en-Y hepaticojejunostomy for choledochal cyst will be allowed oral liquids after confirmation of resumption of bowel function (Positive bowel sounds, passage of stool or flatus, clear NG aspirate)

Other: Post-operative care

ERAS in Biliary Atresia

EXPERIMENTAL

Post-op patients of Roux-en-Y portoenterostomy for biliary atresia will be allowed oral liquids within 24 hours of surgery and NG tube will be removed.

Other: Enhanced Recovery After Surgery

Conventional feeding protocol in Biliary Atresia

ACTIVE COMPARATOR

Post-op patients of portoenterostomy for biliary atresia will be allowed oral feeds only after confirmation of bowel functions (positive bowel sounds, passage of stool or flatus, clearing of NG aspirate)

Other: Post-operative care

Interventions

In ERAS feeding protocol or early oral feeding protocol, patients will be allowed oral liquids within 24 hours of surgery irrespective of confirmation of bowel functions.

Also known as: Fast-tract feeding protocol, Early oral feeding
ERAS Feeding Protocol in Choledochal CystERAS in Biliary Atresia

In conventional feeding protocol, feeds will be resumed after surgery on confirmation of bowel functions with auscultation for bowel sounds or passage of stool or flatus, usually after 48 hours

Also known as: Conventional Feeding Protocol
Conventional Feeding Protocol in Choledochal CystConventional feeding protocol in Biliary Atresia

Eligibility Criteria

Age1 Month - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All children diagnosed with choledochal cyst type I and IV on MRCP or CT scan, undergoing elective Roux-En-Y hepaticojejunostomy
  • All children with provisional diagnosis of biliary atresia undergoing Roux-En-Y portoenterostomy

You may not qualify if:

  • Patients with suspected biliary atresia not undergoing portoenterostomy after Per-op cholangiogram either due to ruling out of disease or advanced disease deemed candidates for liver transplant
  • patients with history of Emergency surgery or external drainage of choledochal cyst
  • Hemodynamically unstable patients after surgery
  • Previous history of GI surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Child Health Sciences, The Children's Hospital, Lahore

Lahore, Punjab Province, 54300, Pakistan

RECRUITING

MeSH Terms

Conditions

Biliary AtresiaCholedochal Cyst

Interventions

Enhanced Recovery After Surgery

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesDigestive System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCystsNeoplasms

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, Operative

Study Officials

  • Sundas Zahra, MBBS

    University of Child Health sciences & The Children's Hospital, Lahore

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhammad Zubair Shoukat, MBBS, FCPS Pediatric Surgery

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

June 13, 2026

First Posted

July 16, 2026

Study Start

July 27, 2024

Primary Completion

July 1, 2026

Study Completion

August 1, 2026

Last Updated

July 16, 2026

Record last verified: 2026-07

Locations